Loop Capital analyst Ananda Baruah maintains NetApp (NASDAQ:NTAP) with a Hold and lowers the price target from $67 to $65.
Needham Reiterates Buy on Cara Therapeutics, Maintains $26 Price Target
Needham analyst Joseph Stringer reiterates Cara Therapeutics (NASDAQ:CARA) with a Buy and maintains $26 price target.